LTS Lohmann Therapie-Systeme
Andernach, Germany
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (5)
○ Clinical Trials
○ SEC Filings
✓ Press (4)
✓ EMA GMP (2)
○ MHRA GMP
✓ HC GMP (9)
Quick Facts: LTS Lohmann Therapie-Systeme
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Andernach, Germany
- Website
- https://www.ltslohmann.com/en/
- Modalities
- Semi-solids & Liquids
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About LTS Lohmann Therapie-Systeme
LTS Lohmann Therapie-Systeme is a contract development and manufacturing organization (CDMO). Capabilities: Semi-solids & Liquids. 4 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://www.ltslohmann.com/en/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
LTS Lohmann Therapie-Systeme FDA Inspection History
2026-07
2025-09
2024-02
2023-06
2022-05
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2026-07-29 |
LTS Lakewood, LLC
Lakewood, New Jersey
Company-level
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
| 2025-09-30 |
LTS Therapy Systems, LLC
Saint Paul, Minnesota
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2024-02-01 |
LTS Lohmann Therapy Systems Corp
West Caldwell, New Jersey
Company-level
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2023-06-06 |
LTS Lakewood, LLC
Lakewood, New Jersey
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2022-05-18 |
LTS Lohmann Therapie-Systeme AG
Andernach
Company-level
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
LTS Lohmann Therapie-Systeme FDA 483 Findings 1 observations · 2026-07-29 → 2026-07-29 ?
By subsystem
By severity
- 2 — Minor: 1
- Repeat observations: 0
Most severe findings
-
Absence of Written Procedures
"Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess."
LTS Lohmann Therapie-Systeme EMA GMP Compliance 2 certificates
2025-03
2025-03
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_RP_01_GMP_2025_0036 | LTS LOHMANN Therapie-Systeme AG | Germany | 2025-03-26 | COMPLIANT |
| DE_RP_01_GMP_2025_0019 | LTS Lohmann Therapie-Systeme AG | Germany | 2025-03-20 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 4 articles
Company announcements, not verified evidence. They do not change any score.
LTS to Acquire Renaissance Lakewood - Contract Pharma
Simtra BioPharma Solutions Appoints Chief Commercial Officer - Contract Pharma
LTS – Your Partner for Innovative Solutions - Pharmaceutical Business review -
LTS, GRAM Enter Strategic Fill Finish Pact for Wearable Injectors - Contract Pharma
Frequently Asked Questions About LTS Lohmann Therapie-Systeme
How many FDA inspections does LTS Lohmann Therapie-Systeme have on record?
CDMO Signal tracks 5 FDA inspections for LTS Lohmann Therapie-Systeme, sourced from the FDA inspection database. See the full inspection history above.
Has LTS Lohmann Therapie-Systeme received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for LTS Lohmann Therapie-Systeme.
Does LTS Lohmann Therapie-Systeme hold EMA or MHRA GMP certificates?
CDMO Signal tracks 2 EMA GMP certificates for LTS Lohmann Therapie-Systeme.
Does LTS Lohmann Therapie-Systeme have a CDMO Signal Score?
Not yet. LTS Lohmann Therapie-Systeme is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating LTS Lohmann Therapie-Systeme for a manufacturing program?
Use the free AI matchmaker to compare LTS Lohmann Therapie-Systeme against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Lichtenheldt
Germany
Semi-solids & Liquids
Pharbil Waltrop (NextPharma)
Germany
Oral Solid Dose, Semi-solids & Liquids
Bayer Contract Manufacturing
Leverkusen, Germany
Oral Solid Dose, Non-sterile Liquids, Semi-solids & Liquids, Sterile Injectables, Lyophilization, Prefilled Syringes, Small Molecule API, High-Potency APIs, Microbial Fermentation
FIDELIO Healthcare Limburg
Limburg an der Lahn, Germany
Non-sterile Liquids, Semi-solids & Liquids, Oral Solid Dose, Controlled Substances, Packaging & Labeling
Formulated Solutions
Largo, Florida, United States
Topicals, Inhalation & Nasal, Finished Dosage Forms, Oral Liquids, Semi-solids & Liquids
Compare LTS Lohmann Therapie-Systeme with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.